Market revenue in 2023 | USD 16.1 million |
Market revenue in 2030 | USD 38.7 million |
Growth rate | 13.4% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Qiagen NV, Abcam PLC, Takara Bio Inc, Revvity Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, HTG Molecular Diagnostics Inc, Meridian Bioscience, New England Biolabs, Norgen Biotek, System Biosciences, Amoy Diagnostics, EntroGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mirna sequencing and assay market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 80.12% in 2023. Horizon Databook has segmented the Germany mirna sequencing and assay market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is one of the key countries in Europe in terms of healthcare. Moreover, favorable government regulations, advanced healthcare, a rising number of drug approvals, and growing concerns regarding drug safety are other key factors driving the Germany miRNA sequencing and assay market. In addition, presence of key service providers in the country is likely to fuel growth of the market.
For instance, Eurofins Genomics offers miRNA/small RNAs sequencing and analysis. Eurofins Genomics offers services such as differential expression analysis of small RNAs and identification of novel small RNAs & target molecules of novel miRNAs.
Presence of such leading products and services providers in miRNA sequencing technology, increasing partnerships between expert universities & organizations, and rising government funding to develop innovative miRNA sequencing & assay products will help impel market growth in this country.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany mirna sequencing and assay market , including forecasts for subscribers. This country databook contains high-level insights into Germany mirna sequencing and assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account